Turtle Creek Wealth Advisors’s Boston Scientific BSX Stock Holding History

Turtle Creek Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$492K	Buy	7,839 +805	+11%	+$64.4K	0.04%	232
2025 Q4	$671K	Buy	7,034 +679	+11%	+$66.6K	0.05%	197
2025 Q3	$620K	Buy	6,355 +2,285	+56%	+$237K	0.06%	191
2025 Q2	$437K	Buy	+4,070	New	+$412K	0.05%	185
2024 Q1	–	Sell	-1,674	Closed	-$96.8K	–	283
2023 Q4	$96.8K	Buy	+1,674	New	+$89.4K	0.03%	204

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Turtle Creek Wealth Advisors's BSX Position: Q1 2026 in Review

Turtle Creek Wealth Advisors increased its Boston Scientific (BSX) stake by 11% in Q1 2026, buying an estimated $64.4K and bringing the position to 7,839 shares worth $492K. The position accounts for 0.04% of the portfolio, ranked #232.

Turtle Creek Wealth Advisors first reported a position in BSX in Q4 2023 and has held it in 5 quarters since. The position peaked at $671K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Turtle Creek Wealth Advisors held 7,839 shares of Boston Scientific worth $492K as of Q1 2026.
Turtle Creek Wealth Advisors bought 805 Boston Scientific shares in Q1 2026, an estimated $64.4K.
Boston Scientific made up 0.04% of Turtle Creek Wealth Advisors's portfolio in Q1 2026, its #232 holding.
Turtle Creek Wealth Advisors first reported a position in Boston Scientific in Q4 2023 and has held it in 5 quarters since.
Turtle Creek Wealth Advisors's Boston Scientific position peaked at $671K in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.